Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 28,537 | 33,879 | 43,107 | 30,168 | 15,141 |
| Cost of Goods | 17,391 | 13,827 | 15,827 | 12,557 | 9,508 |
| Gross Profit | 11,146 | 20,052 | 27,280 | 17,611 | 5,633 |
| Operating Expenses | 51,158 | 45,959 | 62,139 | 59,684 | 58,922 |
| Operating Income | -39,621 | -25,080 | -34,032 | -41,516 | -52,781 |
| Interest Expense | 871 | 15 | 0 | 0 | 0 |
| Other Income | 1,234 | -1,245 | -4,245 | 5,674 | 5,270 |
| Pre-tax Income | -39,258 | -26,340 | -38,277 | -35,842 | -47,511 |
| Income Tax | N/A | -81 | 1,980 | N/A | N/A |
| Net Income Continuous | -39,258 | -26,259 | -40,257 | -35,842 | -47,511 |
| Minority Interests | N/A | 679 | 757 | 812 | 776 |
| Net Income | $-39,258 | $-26,938 | $-41,014 | $-36,654 | $-48,287 |
| EPS Basic Total Ops | -2.56 | -2.02 | -3.01 | -2.69 | -4.37 |
| EPS Basic Continuous Ops | -2.56 | -1.97 | -2.95 | -2.63 | -4.30 |
| EPS Diluted Total Ops | -2.56 | -2.02 | -3.01 | -2.69 | -4.37 |
| EPS Diluted Continuous Ops | -2.56 | -1.97 | -2.95 | -2.63 | -4.30 |
| EPS Diluted Before Non-Recurring Items | -2.56 | -1.86 | -3.01 | -2.60 | -4.30 |
| EBITDA(a) | $-37,290 | $-21,339 | $-31,610 | $-39,701 | $-50,822 |